Financials Scorpius Holdings, Inc.

Equities

SCPX

US42237K4094

Pharmaceuticals

Real-time Estimate Cboe BZX 12:07:07 2024-06-13 pm EDT 5-day change 1st Jan Change
0.098 USD -5.77% Intraday chart for Scorpius Holdings, Inc. -17.25% -77.45%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 31.81 16.22 122.4 77.23 20.66 11.48
Enterprise Value (EV) 1 4.084 3.391 12.46 -17.22 -14.22 23.13
P/E ratio -1.09 x -0.79 x -3.29 x -2.16 x -0.47 x -0.25 x
Yield - - - - - -
Capitalization / Revenue 5.49 x 5.32 x 41.5 x 36.6 x 3.24 x 1.64 x
EV / Revenue 0.7 x 1.11 x 4.23 x -8.15 x -2.23 x 3.31 x
EV / EBITDA -0.24 x -0.18 x -0.51 x 0.52 x 0.33 x -0.67 x
EV / FCF -0.27 x -0.67 x -0.8 x 1.06 x 0.46 x -1.25 x
FCF Yield -366% -149% -126% 93.9% 219% -80.2%
Price to Book 1.05 x 1.18 x 1.04 x 0.69 x 0.28 x 0.37 x
Nbr of stocks (in thousands) 4,637 4,877 22,833 25,404 25,661 26,082
Reference price 2 6.860 3.325 5.360 3.040 0.8051 0.4403
Announcement Date 3/28/19 3/30/20 3/25/21 3/11/22 3/31/23 4/26/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 5.794 3.049 2.948 2.113 6.383 6.995
EBITDA 1 -17.23 -19.16 -24.59 -32.93 -42.5 -34.47
EBIT 1 -17.46 -19.4 -24.93 -33.54 -45.64 -42.03
Operating Margin -301.43% -636.11% -845.51% -1,587.31% -715.02% -600.9%
Earnings before Tax (EBT) 1 -17.58 -20.34 -26.38 -35.55 -47.15 -42.33
Net income 1 -15.73 -20.02 -26.05 -35.07 -43.43 -45.22
Net margin -271.56% -656.51% -883.65% -1,659.95% -680.46% -646.44%
EPS 2 -6.299 -4.210 -1.630 -1.408 -1.700 -1.736
Free Cash Flow 1 -14.95 -5.053 -15.67 -16.18 -31.11 -18.56
FCF margin -258.12% -165.73% -531.53% -765.87% -487.31% -265.32%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/28/19 3/30/20 3/25/21 3/11/22 3/31/23 4/26/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 0.6131 0.2124 0.051 0.0589 0.0799 0.7659 0.6578 0.7231 4.848
EBITDA - - - - - - - - -
EBIT 1 -12.05 -7.477 -9.713 -9.497 -15.5 - -14.32 -11.06 -6.435
Operating Margin -1,964.66% -3,519.7% -19,052.73% -16,134.81% -19,397.1% - -2,176.38% -1,529.43% -132.74%
Earnings before Tax (EBT) 1 -13.75 -8.19 -10.26 -13.31 -15.39 - -14.53 -11.21 -6.507
Net income 1 -13.56 -8.121 -10.16 -13 -12.15 - -13.89 -13.13 -5.408
Net margin -2,212.26% -3,822.89% -19,924.07% -22,086.31% -15,204.55% - -2,111.96% -1,816.06% -111.55%
EPS 2 -0.5400 -0.3200 -0.4000 -0.5100 -0.4800 - -0.5300 -0.5000 -0.2100
Dividend per Share - - - - - - - - -
Announcement Date 3/11/22 5/16/22 8/10/22 11/14/22 3/31/23 5/15/23 8/14/23 11/20/23 4/26/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 11.7
Net Cash position 1 27.7 12.8 110 94.5 34.9 -
Leverage (Debt/EBITDA) - - - - - -0.338 x
Free Cash Flow 1 -15 -5.05 -15.7 -16.2 -31.1 -18.6
ROE (net income / shareholders' equity) -92.1% -93.9% -41% -31.1% -47.6% -82.9%
ROA (Net income/ Total Assets) -37.7% -38% -20.8% -17.1% -25.3% -33.8%
Assets 1 41.77 52.61 125.5 205.1 171.6 133.8
Book Value Per Share 2 6.530 2.810 5.150 4.410 2.880 1.200
Cash Flow per Share 2 4.770 1.870 0.4800 0.3100 0.3300 0.0100
Capex 1 0.59 0.27 0.34 1.9 20.1 1.99
Capex / Sales 10.24% 8.7% 11.46% 90.15% 315.17% 28.39%
Announcement Date 3/28/19 3/30/20 3/25/21 3/11/22 3/31/23 4/26/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.104
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. SCPX Stock
  4. Financials Scorpius Holdings, Inc.